Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in CVKD held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 45K | $231K | — | 1.803% | 0.00% |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 22K | $111K | +48.9% | 0.863% | 0.00% |
| 3 | VANGUARD FIDUCIARY TRUST CO | 8K | $43K | — | 0.332% | 0.00% |
| 4 | BlackRock, Inc. | 5K | $28K | +56.0% | 0.219% | 0.00% |
| 5 | Tower Research Capital LLC (TRC) | 393 | $2K | -26.1% | 0.016% | 0.00% |
| 6 | ADVISOR GROUP HOLDINGS, INC. | 300 | $2K | -40.0% | 0.012% | 0.00% |
| 7 | RWM Asset Management, LLC | 200 | $1K | — | 0.008% | 0.00% |
| 8 | Rockefeller Capital Management L.P. | 150 | $768 | -50.0% | 0.006% | 0.00% |
| 9 | MORGAN STANLEY | 100 | $512 | -90.7% | 0.004% | 0.00% |
| 10 | HARBOUR INVESTMENTS, INC. | 100 | $512 | 0.0% | 0.004% | 0.00% |
| 11 | WELLS FARGO & COMPANY/MN | 99 | $507 | 0.0% | 0.004% | 0.00% |
| 12 | Archer Investment Corp | 35 | $179 | 0.0% | 0.001% | 0.00% |
| 13 | IFP Advisors, Inc | 30 | $154 | 0.0% | 0.001% | 0.00% |
| 14 | Farther Finance Advisors, LLC | 25 | $123 | 0.0% | 0.001% | 0.00% |
| 15 | CALDWELL SUTTER CAPITAL, INC. | 5 | $26 | 0.0% | 0.000% | 0.00% |
| 16 | UBS Group AG | 3 | $15 | -99.7% | 0.000% | 0.00% |
| 17 | Cygnus Capital Advisors, LLC | 1K | $8 | — | 0.060% | 0.00% |
| 18 | CURIO WEALTH, LLC | 1 | $5 | 0.0% | 0.000% | 0.00% |
| 19 | CITIGROUP INC | 1 | $5 | — | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in CVKD — a direct measure of their conviction.
Filings activity in CVKD during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 19 | +0.0% | 4.20% | 2.32 pp | $0M | 36% |
| Q4 2025 | 19 | +0.0% | 6.52% | 9.20 pp | $1M | 58% |
| Q3 2025 | 19 | +5.6% | 15.72% | +7.48 pp | $2M | +91% |
| Q2 2025 | 18 | +5.9% | 8.24% | 3.98 pp | $1M | 33% |
| Q1 2025 | 17 | +70% | 12.22% | +10.14 pp | $1M | +488% |
| Q4 2024 | 10 | +233% | 2.08% | +2.08 pp | $0M | +306106% |
| Q3 2024 | 3 | 70% | 0.00% | 1.53 pp | $0M | 100% |
| Q2 2024 | 10 | — | 1.53% | — | $0M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying CVKD stock.
Based on Q1 2026 13F filings, institutional ownership of Cadrenal Therapeutics, Inc. Common Stock stands at 4.2%, held across 19 reporting institutions.
VANGUARD CAPITAL MANAGEMENT LLC is the largest reported institutional holder of CVKD, with approximately 45,201 shares worth $0.00B as of Q1 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of CVKD.
Our composite Smart Money Score for CVKD is 27 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
5 institutions opened new positions in CVKD during Q1 2026, while 5 fully exited. 2 added to existing positions and 12 trimmed.
CVKD institutional ownership fell by 2.32 percentage points quarter-over-quarter, with a net change of +0 holders.
The top 10 institutions account for 99.8% of all reported 13F value in CVKD, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Cadrenal Therapeutics, Inc. Common Stock (CVKD) Institutional Ownership